North America Pterygium Drug Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	140 Pages	Data Bridge Market Research	October, 2022	DAABD17480602

Best Price Guarantee
Price	from $3,500
Length	140 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2022
SKU	DAABD17480602

North America Pterygium Drug Market - Industry Trends and Forecast to 2029

The North America pterygium drug market is projected to register a substantial CAGR of 5.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

North America Pterygium Drug Market, By Type (Progressive Pterygium and Atrophic Pterygium), Stages (Stage 2, Stage 3, Stage 1), Treatment (Artificial Tears/Topical Lubricants and Steroid Eye Drops.), Formulation (Eye Drops, Eye Ointments, Others), Mode of Purchase (Prescription and Over the Counter (OTC)), Population Type (Geriatric and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of North America pterygium drug market are:
• Increase in healthcare awareness to reduce the risk of eye illnesses
• Rising geriatric population

Market Players

Some of the major players operating in the North America pterygium drug market are:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Akorn Operating Company LLC
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Prestige Consumer Healthcare Inc.
• Bayer AG
• Zydus Group
• Amneal Pharmaceuticals LLC
• OASIS Medical
• Alcon
• Santen Pharmaceutical Co.Companies

• Johnson & Johnson Services, Inc.
• Novartis AG
• Akorn Operating Company LLC
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Prestige Consumer Healthcare Inc.
• Bayer AG
• Zydus Group
• Amneal Pharmaceuticals LLC
• OASIS Medical
• Alcon
• Santen Pharmaceutical Co.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of North America Pterygium Drug Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 North America Pterygium Drug Market: Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Class Segment Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End User Coverage Grid; 2.11 Secondary Sources
3 Executive Summary
4 Premium Insights: 4.1 Pestel's Model; 4.2 Porter's 5 Forces; 4.3 Epidemiology; 4.4 North-america Pterygium Drug Market: Number Of Surgeries
5 Pipeline Analysis
6 North-america Pterygium Drug Market: Regulations: 6.1 Regulation In The North-america
7 Market Overview: 7.1 Drivers; 7.1.1 Rise In Incidences And Prevalence Of Ophthalmic Disorders; 7.1.2 Rise In Geriatric Population; 7.1.3 Increase In Healthcare Awareness To Reduce The Risk Of Eye Illnesses; 7.2 Restraints; 7.2.1 High Cost Of Eye Treatment And Medication; 7.2.2 Side Effects Of Steroids Eye Drops; 7.3 Opportunities; 7.3.1 Programs And Initiatives To Reduce The Burden Of Eye Diseases; 7.3.2 Rise In Healthcare Expenditure And Disposable Income; 7.3.3 Increase In Research And Development Activities; 7.4 Challenges; 7.4.1 Stringent Rules & Regulations; 7.4.2 Exposure To Ultraviolet Radiations
8 North America Pterygium Drug Market, By Disease Type: 8.1 Overview; 8.2 Progressive Pterygium; 8.3 Atrophic Pterygium
9 North America Pterygium Drug Market, By Stages: 9.1 Overview; 9.2 Stage 2; 9.3 Stage 3; 9.4 Stage 1
10 North America Pterygium Drug Market, By Treatment: 10.1 Overview; 10.2 Artificial Tears/Topical Lubricants; 10.2.1 Demulcent; 10.2.2 Emollients; 10.3 Steroid Eye Drops; 10.3.1 Ketone Steroids; 10.3.1.1 Prednosolone; 10.3.1.2 Dexamethasone; 10.3.1.3 Flurometholone; 10.3.1.4 Others; 10.3.2 Ester Steroid (Loterprednol)
11 North America Pterygium Drug Market, By Formulation: 11.1 Overview; 11.2 Eye Drops; 11.2.1 Eye Drops With Preservatives; 11.2.2 Preservative-free Eye Drops; 11.3 Eye Ointments; 11.4 Others
12 North America Pterygium Drug Market, By Mode Of Purchase: 12.1 Overview; 12.2 Prescription; 12.3 Over The Counter (Otc)
13 North America Pterygium Drug Market, By Population Type: 13.1 Overview; 13.2 Geriatric; 13.3 Adults
14 North America Pterygium Drug Market, By End User: 14.1 Overview; 14.2 Hospitals; 14.3 Specialty Clinics; 14.4 Home Healthcare; 14.5 Others
15 North America Pterygium Drug Market, By Distribution Channel: 15.1 Overview; 15.2 Retail Pharmacies; 15.3 Hospital Pharmacies; 15.4 Online Pharmacies; 15.5 Others
16 North America Pterygium Drug Market, By Country: 16.1 U.S.; 16.2 Mexico; 16.3 Canada
17 North America Pterygium Drug Market: Company Landscape: 17.1 Company Share Analysis: North America
18 Swot Analysis
19 Company Profile: 19.1 Alcon; 19.1.1 Company Snapshot; 19.1.2 Recent Financials; 19.1.3 Product Portfolio; 19.1.4 Recent Developments; 19.2 Abbvie Inc.; 19.2.1 Company Snapshot; 19.2.2 Revenue Analysis; 19.2.3 Product Portfolio; 19.2.4 Recent Development; 19.3 Bausch & Lomb Incorporated; 19.3.1 Company Snapshot; 19.3.2 Revenue Analysis; 19.3.3 Product Portfolio; 19.3.4 Recent Development; 19.4 Johnson & Johnson Services, Inc.; 19.4.1 Company Snapshot; 19.4.2 Revenue Analysis; 19.4.3 Product Portfolio; 19.4.4 Recent Developments; 19.5 Bayer Ag; 19.5.1 Company Snapshot; 19.5.2 Revenue Analysis; 19.5.3 Product Portfolio; 19.5.4 Recent Developments; 19.6 Akorn Operating Company Llc; 19.6.1 Company Snapshot; 19.6.2 Product Portfolio; 19.6.3 Recent Development; 19.7 Amneal Pharmaceuticals Llc.; 19.7.1 Company Snapshot; 19.7.2 Revenue Analysis; 19.7.3 Product Portfolio; 19.7.4 Recent Developments; 19.8 Novartis Ag; 19.8.1 Company Snapshot; 19.8.2 Revenue Analysis; 19.8.3 Product Portfolio; 19.8.4 Recent Developments; 19.9 Oasis Medical; 19.9.1 Company Snapshot; 19.9.2 Product Portfolio; 19.9.3 Recent Developments; 19.10 Prestige Consumer Healthcare Inc.; 19.10.1 Company Snapshot; 19.10.2 Revenue Analysis; 19.10.3 Product Portfolio; 19.10.4 Recent Development; 19.11 Santen Pharmaceutical Co., Ltd.; 19.11.1 Company Snapshot; 19.11.2 Recent Financials; 19.11.3 Product Portfolio; 19.11.4 Recent Development; 19.12 Similasan Corporation; 19.12.1 Company Snapshot; 19.12.2 Product Portfolio; 19.12.3 Recent Developments; 19.13 Théa Laboratories; 19.13.1 Company Snapshot; 19.13.2 Product Portfolio; 19.13.3 Recent Developments; 19.14 Wellona Pharma; 19.14.1 Company Snapshot; 19.14.2 Product Portfolio; 19.14.3 Recent Developments; 19.15 Zydus Group; 19.15.1 Company Snapshot; 19.15.2 Revenue Analysis; 19.15.3 Product Portfolio; 19.15.4 Recent Developments
20 Questionnaire
21 Related Reports 140
List Of Tables: Table 1 North-america Pterygium Drug Market, Pipeline Analysis; Table 2 North America Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million); Table 3 North America Pterygium Drug Market, By Stages, 2020-2029 (Usd Million); Table 4 North America Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million); Table 5 North America Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 6 North America Steroid Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 7 North America Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 8 North America Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 9 North America Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 10 North America Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million); Table 11 North America Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million); Table 12 North America Pterygium Drug Market, By End User, 2020-2029 (Usd Million); Table 13 North America Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million); Table 14 North America Pterygium Drug Market, By Country, 2020-2029 (Usd Million); Table 15 U.S. Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million); Table 16 U.S. Pterygium Drug Market, By Stages, 2020-2029 (Usd Million); Table 17 U.S. Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million); Table 18 U.S. Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 19 U.S. Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 20 U.S. Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 21 U.S. Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 22 U.S. Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 23 U.S. Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million); Table 24 U.S. Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million); Table 25 U.S. Pterygium Drug Market, By End User, 2020-2029 (Usd Million); Table 26 U.S. Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million); Table 27 Mexico Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million); Table 28 Mexico Pterygium Drug Market, By Stages, 2020-2029 (Usd Million); Table 29 Mexico Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million); Table 30 Mexico Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 31 Mexico Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 32 Mexico Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 33 Mexico Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 34 Mexico Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 35 Mexico Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million); Table 36 Mexico Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million); Table 37 Mexico Pterygium Drug Market, By End User, 2020-2029 (Usd Million); Table 38 Mexico Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million); Table 39 Canada Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million); Table 40 Canada Pterygium Drug Market, By Stages, 2020-2029 (Usd Million); Table 41 Canada Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million); Table 42 Canada Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 43 Canada Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 44 Canada Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million); Table 45 Canada Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 46 Canada Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million); Table 47 Canada Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million); Table 48 Canada Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million); Table 49 Canada Pterygium Drug Market, By End User, 2020-2029 (Usd Million); Table 50 Canada Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures: Figure 1 North America Pterygium Drug Market: Segmentation; Figure 2 North America Pterygium Drug Market: Data Triangulation; Figure 3 North America Pterygium Drug Market: Droc Analysis; Figure 4 North America Pterygium Drug Market: North America Vs Regional Market Analysis; Figure 5 North America Pterygium Drug Market: Company Research Analysis; Figure 6 North America Pterygium Drug Market: Interview Demographics; Figure 7 North America Pterygium Drug Market: Dbmr Position Grid; Figure 8 North America Pterygium Drug Market: Vendor Share Analysis; Figure 9 North America Pterygium Drug Market: End User Coverage Grid; Figure 10 North America Pterygium Drug Market: Segmentation; Figure 11 Increasing Prevalence Of Ophthalmic Disorders And Rise In Geriatric Population Are Expected To Drive The North America Pterygium Drug Market From 2022 To 2029; Figure 12 Progressive Pterygium Is Expected To Have The Largest Share Of The North America Pterygium Drug Market From 2022 & 2029; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North-america Pterygium Drug Market; Figure 14 North America Pterygium Drug Market: By Disease Type, 2021; Figure 15 North America Pterygium Drug Market: By Disease Type, 2022-2029 (Usd Million); Figure 16 North America Pterygium Drug Market: By Disease Type, Cagr (2022-2029); Figure 17 North America Pterygium Drug Market: By Disease Type, Lifeline Curve; Figure 18 North America Pterygium Drug Market: By Stages, 2021; Figure 19 North America Pterygium Drug Market: By Stages, 2022-2029 (Usd Million); Figure 20 North America Pterygium Drug Market: By Stages, Cagr (2022-2029); Figure 21 North America Pterygium Drug Market: By Stages, Lifeline Curve; Figure 22 North America Pterygium Drug Market: By Treatment, 2021; Figure 23 North America Pterygium Drug Market: By Treatment, 2022-2029 (Usd Million); Figure 24 North America Pterygium Drug Market: By Treatment, Cagr (2022-2029); Figure 25 North America Pterygium Drug Market: By Treatment, Lifeline Curve; Figure 26 North America Pterygium Drug Market: By Formulation, 2021; Figure 27 North America Pterygium Drug Market: By Formulation, 2022-2029 (Usd Million); Figure 28 North America Pterygium Drug Market: By Formulation, Cagr (2022-2029); Figure 29 North America Pterygium Drug Market: By Formulation, Lifeline Curve; Figure 30 North America Pterygium Drug Market: By Mode Of Purchase, 2021; Figure 31 North America Pterygium Drug Market: By Mode Of Purchase, 2022-2029 (Usd Million); Figure 32 North America Pterygium Drug Market: By Mode Of Purchase, Cagr (2022-2029); Figure 33 North America Pterygium Drug Market: By Mode Of Purchase, Lifeline Curve; Figure 34 North America Pterygium Drug Market: By Population Type, 2021; Figure 35 North America Pterygium Drug Market: By Population Type, 2022-2029 (Usd Million); Figure 36 North America Pterygium Drug Market: By Population Type, Cagr (2022-2029); Figure 37 North America Pterygium Drug Market: By Population Type, Lifeline Curve; Figure 38 North America Pterygium Drug Market: By End User, 2021; Figure 39 North America Pterygium Drug Market: By End User, 2022-2029 (Usd Million); Figure 40 North America Pterygium Drug Market: By End User, Cagr (2022-2029); Figure 41 North America Pterygium Drug Market: By End User, Lifeline Curve; Figure 42 North America Pterygium Drug Market: By Distribution Channel, 2021; Figure 43 North America Pterygium Drug Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 44 North America Pterygium Drug Market: By Distribution Channel, Cagr (2022-2029); Figure 45 North America Pterygium Drug Market: By Distribution Channel, Lifeline Curve; Figure 46 North America Pterygium Drug Market: Snapshot (2021); Figure 47 North America Pterygium Drug Market: By Country (2021); Figure 48 North America Pterygium Drug Market: By Country (2022 & 2029); Figure 49 North America Pterygium Drug Market: By Country (2021 & 2029); Figure 50 North America Pterygium Drug Market: By Disease Type (2022-2029); Figure 51 North America Pterygium Drug Market: Company Share 2021 (%) 107